Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$24.07
-1.07-4.26%
At close: Nov 14, 4:00 PM EST
$24.07
N/A
After Hours: Nov 14, 4:00 PM EST
Comments
Loading...
BioLife Solutions Analyst Ratings and Price Targets | NASDAQ:BLFS | Benzinga
BioLife Solutions Inc has a consensus price target of $28.75 based on the ratings of 12 analysts. The high is $33 issued by Keybanc on December 13, 2024. The low is $22 issued by Jefferies on April 4, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on August 8, 2025, May 13, 2025, and March 6, 2025, respectively. With an average price target of $30.67 between HC Wainwright & Co., there's an implied 27.41% upside for BioLife Solutions Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Northland Capital Markets
Benchmark
Keybanc
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for BioLife Solutions
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/08/2025 | 32.95% | HC Wainwright & Co. | $30 → $32 | Maintains | Buy | |||
05/13/2025 | 24.64% | HC Wainwright & Co. | $30 → $30 | Reiterates | Buy → Buy | |||
03/06/2025 | 24.64% | HC Wainwright & Co. | $27 → $30 | Maintains | Buy | |||
01/08/2025 | 28.79% | Northland Capital Markets | $28 → $31 | Maintains | Outperform | |||
12/19/2024 | 24.64% | Benchmark | $30 → $30 | Reiterates | Buy → Buy | |||
12/13/2024 | 37.1% | Keybanc | $30 → $33 | Maintains | Overweight | |||
11/18/2024 | 12.17% | HC Wainwright & Co. | $29 → $27 | Maintains | Buy | |||
11/13/2024 | 28.79% | TD Cowen | $28 → $31 | Maintains | Buy | |||
11/13/2024 | 32.95% | Craig-Hallum | $30 → $32 | Maintains | Buy | |||
09/30/2024 | 20.48% | HC Wainwright & Co. | → $29 | Initiates | → Buy | |||
08/12/2024 | 24.64% | Craig-Hallum | $23 → $30 | Maintains | Buy | |||
08/09/2024 | 16.33% | Northland Capital Markets | $26 → $28 | Maintains | Outperform | |||
07/17/2024 | 8.02% | TD Cowen | $20 → $26 | Maintains | Buy | |||
05/13/2024 | 3.86% | Benchmark | → $25 | Upgrade | Hold → Buy | |||
04/04/2024 | -8.6% | Jefferies | → $22 | Initiates | → Buy | |||
08/10/2023 | -4.45% | Craig-Hallum | $29 → $23 | Maintains | Buy | |||
08/09/2023 | 3.86% | TD Cowen | $29 → $25 | Maintains | Outperform | |||
08/09/2023 | 3.86% | Lake Street | $34 → $25 | Maintains | Buy | |||
07/17/2023 | 20.48% | Stephens & Co. | $27 → $29 | Maintains | Overweight | |||
07/11/2023 | 20.48% | Craig-Hallum | → $29 | Initiates | → Buy | |||
03/17/2023 | 12.17% | Stephens & Co. | $31 → $27 | Maintains | Overweight | |||
03/06/2023 | 16.33% | Oppenheimer | → $28 | Reiterates | → Outperform |
FAQ
What is the target price for BioLife Solutions (BLFS) stock?
The latest price target for BioLife Solutions (NASDAQ:BLFS) was reported by HC Wainwright & Co. on August 8, 2025. The analyst firm set a price target for $32.00 expecting BLFS to rise to within 12 months (a possible 32.95% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BioLife Solutions (BLFS)?
The latest analyst rating for BioLife Solutions (NASDAQ:BLFS) was provided by HC Wainwright & Co., and BioLife Solutions maintained their buy rating.
When was the last upgrade for BioLife Solutions (BLFS)?
The last upgrade for BioLife Solutions Inc happened on May 13, 2024 when Benchmark raised their price target to $25. Benchmark previously had a hold for BioLife Solutions Inc.
When was the last downgrade for BioLife Solutions (BLFS)?
There is no last downgrade for BioLife Solutions.
When is the next analyst rating going to be posted or updated for BioLife Solutions (BLFS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioLife Solutions, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioLife Solutions was filed on August 8, 2025 so you should expect the next rating to be made available sometime around August 8, 2026.
Is the Analyst Rating BioLife Solutions (BLFS) correct?
While ratings are subjective and will change, the latest BioLife Solutions (BLFS) rating was a maintained with a price target of $30.00 to $32.00. The current price BioLife Solutions (BLFS) is trading at is $24.07, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
